
معرفی
Professor Andrew Crowden is a prominent bioethicist and philosopher affiliated with the University of Queensland (School of Historical and Philosophical Inquiry, Faculty of Humanities, Arts and Social Sciences) and holds additional roles as Honorary Professorial Fellow at the University of Melbourne and Adjunct Professor at the University of the Sunshine Coast. His expertise spans clinical, research, and organizational ethics, with a focus on genomics, data science, and Indigenous health.
- Honorary Professor, University of Queensland
- Honorary Professorial Fellow, University of Melbourne
- Adjunct Professor, University of the Sunshine Coast
- Chair, University of Queensland Ethics Advisory Group (UQEAG)
- Director, Crowden Consultants
Research Interests: Crowden's work explores the intersection of bioethics, philosophy, and place-based ethics. Key areas include genomic ethics, data science governance, genetic counseling, and Indigenous healthcare. His scholarship addresses consent in precision medicine, virtue ethics in clinical practice, and ethical challenges in biobanking.
Scientific Contributions: Recent publications analyze place-based decision-making in gene editing, genetic determinism, and digital ethics in surveillance economies. His 2024 book Power and Ethics: Finding Freedom Through Critique synthesizes these themes.
Scientific Awards:
- Honorary Professorial Fellow, University of Melbourne
- Adjunct Professor, University of the Sunshine Coast
- Stream Leader for Research and Innovation, Australasian Association of Bioethics and Health Law (AABHL)
Supervision & Grants: Crowden advises PhD candidates on topics like digital ethics and trust in surveillance economies. Funded by institutions such as the John Templeton Foundation and Queensland Genomic Health Alliance, his research addresses ethical governance of genomic data and professional boundaries in rural healthcare.
Labs & Teams: He leads the University of Queensland Ethics Advisory Group, contributes to the Australian Health Biobank Advisory Group, and collaborates with the Australasian Association of Bioethics and Health Law.


